Live Webinar: Ion Mobility/Mass Spectrometry for Metabolomics & Clinical Research Analysis

Join Agilent for a live webinar

Ion mobility/mass spectrometry has tremendous potential for metabolomics, lipidomics, and clinical research analysis. Ion mobility can resolve compounds unresolved by LC/MS/MS, provide additional structural information not available from mass spectrometry, and reduce or eliminate the need for chromatographic separation. These features offer significant improvements for quantitative targeted metabolomics and clinical research analysis, as well as for untargeted (global) metabolomics studies.

This presentation will explore innovations in ion mobility/mass spectrometry for metabolomics, lipidomics, and clinical research analysis. Techniques to be covered include both classic drift tube ion mobility (IMS) and high-field asymmetric-waveform ion mobility (FAIMS), in conjunction with HRMS, MS/MS, and LC/MS.

 

Key learning objectives:

  • To understand how ion mobility is combined with mass spectrometry
  • To understand how in mobility/mass spectrometry can be used for clinical research analysis and metabolomics

REGISTER NOW

 

Monday
April 30, 2018

8:00 a.m. PDT
11:00 a.m. EDT

Presenter

Richard A Yost
University of Florida Director
NIH Southeast Center for Integrated Metabolomics

 

REGISTER

For Research Use Only. Not for use in diagnostic procedures.

 

Agilent Home  |  About Agilent  |  Legal  |  Subscriptions

5301 Stevens Creek Blvd, Santa Clara CA 95051, USA

Agilent is committed to respecting and protecting your privacy. To view the promises that we make to you regarding your personal information, please view Agilent's privacy statement. For questions related to privacy, please send your inquiry to privacy_advocate@agilent.com. If you prefer not to receive promotional e-mails from Agilent in the future, you can unsubscribe at any time. You can also update your e-mail address, contact information, or interest profile to ensure you receive the most relevant information.

ⓒ Agilent Technologies, Inc. 2018

Wróć